| http://www.w3.org/ns/prov#value | - While the marketers described the key study as being ???randomized, double-blind, placebo-controlled??? ??? the gold standard for clinical studies ??? the FTC argued the study was insufficient to support the claims, pointing to problems such as a small sample size and unreliable results.
|
